Conrad P. Hodgkinson

2.5k total citations
58 papers, 1.9k citations indexed

About

Conrad P. Hodgkinson is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Conrad P. Hodgkinson has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 20 papers in Surgery and 8 papers in Genetics. Recurrent topics in Conrad P. Hodgkinson's work include Tissue Engineering and Regenerative Medicine (13 papers), Pluripotent Stem Cells Research (12 papers) and Congenital heart defects research (11 papers). Conrad P. Hodgkinson is often cited by papers focused on Tissue Engineering and Regenerative Medicine (13 papers), Pluripotent Stem Cells Research (12 papers) and Congenital heart defects research (11 papers). Conrad P. Hodgkinson collaborates with scholars based in United States, United Kingdom and China. Conrad P. Hodgkinson's co-authors include Victor J. Dzau, Shu Ye, José A. Gómez, Maria Mirotsou, Richard E. Pratt, Graham J. Sale, Akshay Bareja, Sophie Dal-Pra, Kunal P. Patel and Ross C. Laxton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Conrad P. Hodgkinson

57 papers receiving 1.9k citations

Peers

Conrad P. Hodgkinson
Kyung U. Hong United States
Rabea Hinkel Germany
Mirjam B. Smeets Netherlands
Tom Doetschman United States
Conrad P. Hodgkinson
Citations per year, relative to Conrad P. Hodgkinson Conrad P. Hodgkinson (= 1×) peers Liangpeng Li

Countries citing papers authored by Conrad P. Hodgkinson

Since Specialization
Citations

This map shows the geographic impact of Conrad P. Hodgkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad P. Hodgkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad P. Hodgkinson more than expected).

Fields of papers citing papers by Conrad P. Hodgkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad P. Hodgkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad P. Hodgkinson. The network helps show where Conrad P. Hodgkinson may publish in the future.

Co-authorship network of co-authors of Conrad P. Hodgkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Conrad P. Hodgkinson. A scholar is included among the top collaborators of Conrad P. Hodgkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conrad P. Hodgkinson. Conrad P. Hodgkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xinghua, et al.. (2024). The impact of aging on cardiac repair and regeneration. Journal of Biological Chemistry. 300(9). 107682–107682. 5 indexed citations
2.
Wang, Xinghua, et al.. (2024). Modifying miRs for effective reprogramming of fibroblasts to cardiomyocytes. Molecular Therapy — Nucleic Acids. 35(2). 102160–102160. 2 indexed citations
3.
Dzau, Victor J. & Conrad P. Hodgkinson. (2024). RNA Therapeutics for the Cardiovascular System. Circulation. 149(9). 707–716. 25 indexed citations
4.
Sun, Hualing, Xinghua Wang, Richard E. Pratt, Victor J. Dzau, & Conrad P. Hodgkinson. (2024). C166 EVs potentiate miR cardiac reprogramming via miR-148a-3p. Journal of Molecular and Cellular Cardiology. 190. 48–61. 3 indexed citations
5.
Pratt, Richard E., et al.. (2024). Skeletal muscle differentiation induces wide-ranging nucleosome repositioning in muscle gene promoters. Scientific Reports. 14(1). 9396–9396. 1 indexed citations
6.
Dzau, Victor J. & Conrad P. Hodgkinson. (2023). Precision Hypertension. Hypertension. 81(4). 702–708. 45 indexed citations
7.
Sun, Hualing, Richard E. Pratt, Victor J. Dzau, & Conrad P. Hodgkinson. (2023). Neonatal and adult cardiac fibroblasts exhibit inherent differences in cardiac regenerative capacity. Journal of Biological Chemistry. 299(5). 104694–104694. 13 indexed citations
8.
Pratt, Richard E., et al.. (2023). Novel method of differentiating human induced pluripotent stem cells to mature cardiomyocytes via Sfrp2. Scientific Reports. 13(1). 3920–3920. 11 indexed citations
9.
Pratt, Richard E., et al.. (2022). A novel Cbx1, PurB, and Sp3 complex mediates long-term silencing of tissue- and lineage-specific genes. Journal of Biological Chemistry. 298(6). 102053–102053. 8 indexed citations
10.
Sun, Hualing, Conrad P. Hodgkinson, Richard E. Pratt, & Victor J. Dzau. (2021). CRISPR/Cas9 Mediated Deletion of the Angiotensinogen Gene Reduces Hypertension: A Potential for Cure?. Hypertension. 77(6). 1990–2000. 16 indexed citations
11.
Kang, Martin H., Jiabiao Hu, Richard E. Pratt, et al.. (2020). Optimizing delivery for efficient cardiac reprogramming. Biochemical and Biophysical Research Communications. 533(1). 9–16. 19 indexed citations
12.
Dal-Pra, Sophie, Conrad P. Hodgkinson, & Victor J. Dzau. (2019). Induced cardiomyocyte maturation: Cardiac transcription factors are necessary but not sufficient. PLoS ONE. 14(10). e0223842–e0223842. 19 indexed citations
13.
Bareja, Akshay, et al.. (2018). The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)–IGF1 receptor pathway. Journal of Biological Chemistry. 293(17). 6449–6459. 13 indexed citations
14.
Bareja, Akshay, Conrad P. Hodgkinson, Alan Payne, Richard E. Pratt, & Victor J. Dzau. (2014). Abstract 15731: Hypoxia and Akt Induced Stem Cell Factor Exerts Cardioprotective Effects via Specific Binding to the Insulin-Like Growth Factor-1 Receptor. Circulation. 130. 1 indexed citations
15.
Hodgkinson, Conrad P., José A. Gómez, Maria Mirotsou, & Victor J. Dzau. (2010). Genetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy. Human Gene Therapy. 21(11). 1513–1526. 123 indexed citations
16.
Hodgkinson, Conrad P., et al.. (2008). 80K-H Acts as a Signaling Bridge in Intact Living Cells Between PKCζ and the GLUT4 Translocation Regulator Munc18c. Journal of Receptors and Signal Transduction. 28(6). 581–589. 3 indexed citations
17.
Decock, Julie, Jirong Long, Ross C. Laxton, et al.. (2007). Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis. Cancer Research. 67(21). 10214–10221. 79 indexed citations
18.
Kyriakou, Theodosios, Enrique Viturro, Conrad P. Hodgkinson, et al.. (2007). Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. Human Molecular Genetics. 16(12). 1412–1422. 17 indexed citations
19.
Mander, Ann, Conrad P. Hodgkinson, & Graham J. Sale. (2005). Knock‐down of LAR protein tyrosine phosphatase induces insulin resistance. FEBS Letters. 579(14). 3024–3028. 19 indexed citations
20.
Hodgkinson, Conrad P., Ann Mander, & Graham J. Sale. (2005). Protein kinase-ζ interacts with munc18c: role in GLUT4 trafficking. Diabetologia. 48(8). 1627–1636. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026